The U.S. Food and Drug Administration (FDA) flagged a shortage of albuterol, a medication used to treat some breathing conditions, including asthma, after its manufacturer stopped producing it.
“FDA is working to address a shortage of a particular form of albuterol … a medication that is used to treat breathing conditions. It is important to note that this shortage does not impact albuterol inhalers for personal use,” according to a post from the FDA on Wednesday evening.
The FDA flagged the aerosolized form of albuterol that is used in hospitals and nursing homes across the United States. According to the regulator, the shortage only impacts a particular dosage of the medication generally used in hospitals and does not impact albuterol inhalers for personal use….